Division of Endocrinology, Department of Medicine, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada.
Division of Neurology, Department of Medicine, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada.
Endocr Rev. 2023 Mar 4;44(2):143-192. doi: 10.1210/endrev/bnac015.
Brown adipose tissue (BAT) displays the unique capacity to generate heat through uncoupled oxidative phosphorylation that makes it a very attractive therapeutic target for cardiometabolic diseases. Here, we review BAT cellular metabolism, its regulation by the central nervous and endocrine systems and circulating metabolites, the plausible roles of this tissue in human thermoregulation, energy balance, and cardiometabolic disorders, and the current knowledge on its pharmacological stimulation in humans. The current definition and measurement of BAT in human studies relies almost exclusively on BAT glucose uptake from positron emission tomography with 18F-fluorodeoxiglucose, which can be dissociated from BAT thermogenic activity, as for example in insulin-resistant states. The most important energy substrate for BAT thermogenesis is its intracellular fatty acid content mobilized from sympathetic stimulation of intracellular triglyceride lipolysis. This lipolytic BAT response is intertwined with that of white adipose (WAT) and other metabolic tissues, and cannot be independently stimulated with the drugs tested thus far. BAT is an interesting and biologically plausible target that has yet to be fully and selectively activated to increase the body's thermogenic response and shift energy balance. The field of human BAT research is in need of methods able to directly, specifically, and reliably measure BAT thermogenic capacity while also tracking the related thermogenic responses in WAT and other tissues. Until this is achieved, uncertainty will remain about the role played by this fascinating tissue in human cardiometabolic diseases.
棕色脂肪组织 (BAT) 通过解耦的氧化磷酸化产生热量的独特能力使其成为治疗心脏代谢疾病的极具吸引力的治疗靶点。在这里,我们回顾了 BAT 的细胞代谢、其受中枢神经系统和内分泌系统以及循环代谢物的调节、该组织在人类体温调节、能量平衡和心脏代谢紊乱中的可能作用,以及其在人类中的药理学刺激的现有知识。目前,人体研究中 BAT 的定义和测量几乎完全依赖于正电子发射断层扫描 (PET) 中 18F-氟脱氧葡萄糖摄取来测定 BAT 葡萄糖摄取,这可以与 BAT 产热活性分离,例如在胰岛素抵抗状态下。BAT 产热的最重要能量底物是其细胞内脂肪酸含量,这是通过交感神经刺激细胞内甘油三酯脂肪分解而动员的。这种脂肪分解的 BAT 反应与白色脂肪 (WAT) 和其他代谢组织的反应交织在一起,并且迄今为止,用测试的药物无法独立地刺激这种反应。BAT 是一个有趣且具有生物学合理性的靶点,尚未被完全和选择性地激活以增加身体的产热反应并改变能量平衡。人体 BAT 研究领域需要能够直接、特异性和可靠地测量 BAT 产热能力的方法,同时还能跟踪 WAT 和其他组织中的相关产热反应。在实现这一目标之前,人们对该迷人组织在人类心脏代谢疾病中所起的作用仍存在不确定性。